Cargando…
Engineering targeted viral vectors for gene therapy
To achieve therapeutic success, transfer vehicles for gene therapy must be capable of transducing target cells while avoiding impact on non-target cells. Despite the high transduction efficiency of viral vectors, their tropism frequently does not match the therapeutic need. In the past, this lack of...
Autores principales: | Waehler, Reinhard, Russell, Stephen J., Curiel, David T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097627/ https://www.ncbi.nlm.nih.gov/pubmed/17607305 http://dx.doi.org/10.1038/nrg2141 |
Ejemplares similares
-
Next-Generation Gene Therapy for Parkinson’s Disease Using Engineered Viral Vectors
por: Björklund, Tomas, et al.
Publicado: (2021) -
Viral Vectors in Gene Therapy
por: Lundstrom, Kenneth
Publicado: (2018) -
Engineering influenza viral vectors
por: Li, Junwei, et al.
Publicado: (2013) -
Designer Gene Delivery Vectors: Molecular Engineering and Evolution of Adeno-Associated Viral Vectors for Enhanced Gene Transfer
por: Kwon, Inchan, et al.
Publicado: (2007) -
Viral Vector-Based Gene Therapy
por: Li, Xuedan, et al.
Publicado: (2023)